Skip to content

Xtant Medical Holdings XTNT Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin62.3%-0.6pp62.9%+0.9pp62%+1.9pp60.2%+2.0pp58.2%0.0pp
Net margin1.5%-2.2pp3.7%+2.4pp1.3%
Returns
Return on equity3.9%-6.6pp10.6%+6.9pp3.6%
Return on invested capital5.8%-7.7pp13.5%+5.4pp8%+8.0pp0%+12.3pp-12.3%+7.2pp
Efficiency
Asset turnover1.4×0.0×1.4×+0.1×1.3×0.0×1.3×0.0×1.3×0.0×
Liquidity
Current ratio3.3×+0.7×2.7×+0.4×2.2×-0.3×2.5×+0.1×2.3×0.0×
Leverage
Debt-to-equity0.3×0.0×0.4×-0.1×0.4×-0.1×0.5×0.0×0.5×0.0×
Net debt / EBITDA0.3×
Per Share
Book value per share$0.35+2.2%$0.34+1.4%$0.34+2.6%$0.33+6.6%$0.31-4.8%
Valuation
Market capitalization$59.05M-32.5%$109.76M+20.8%$90.85M+2.5%$88.61M+35.6%$65.36M+6.1%
Price / sales0.5×-0.2×0.8×+0.1×0.7×0.0×0.7×+0.2×0.5×0.0×
Price / book1.2×-0.6×2.2×+0.4×1.8×0.0×1.8×+0.3×1.5×+0.1×
EV / EBITDA5.4×-17.7×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Xtant Medical Holdings's profit margins?
Xtant Medical Holdings (XTNT) runs a 62.3% gross margin and a 4.8% operating margin, with a 1.5% net margin.
Where do Xtant Medical Holdings's ratios come from?
Every ratio is computed from Xtant Medical Holdings's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.